NCT07285590
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07285590
Title Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma (IMCL-2023)
Acronym IMCL-2023
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.